- Report
- February 2024
- 181 Pages
Global
From €3236EUR$3,600USD£2,809GBP
- Report
- February 2024
- 100 Pages
Europe
From €1348EUR$1,500USD£1,170GBP
- Report
- March 2023
- 78 Pages
Middle East, Africa
From €1348EUR$1,500USD£1,170GBP
- Report
- March 2023
- 78 Pages
Asia Pacific
From €1348EUR$1,500USD£1,170GBP
- Report
- March 2023
- 78 Pages
Europe
From €1348EUR$1,500USD£1,170GBP
- Report
- March 2023
- 70 Pages
North America
From €1348EUR$1,500USD£1,170GBP
- Report
- March 2023
- 170 Pages
Global
From €3236EUR$3,600USD£2,809GBP
- Report
- February 2022
- 37 Pages
Global
From €1798EUR$2,000USD£1,561GBP
- Report
- February 2022
- 80 Pages
Global
From €1798EUR$2,000USD£1,561GBP
- Drug Pipelines
- October 2020
- 773 Pages
Global
From €1798EUR$2,000USD£1,561GBP
- Drug Pipelines
- August 2020
- 345 Pages
Global
From €1798EUR$2,000USD£1,561GBP
- Drug Pipelines
- July 2020
- 197 Pages
Global
From €1798EUR$2,000USD£1,561GBP
- Report
- October 2021
- 293 Pages
Global
From €4000EUR$4,450USD£3,472GBP
- Report
- January 2025
- 191 Pages
Global
From €4490EUR$4,995USD£3,897GBP
- Report
- May 2024
- 193 Pages
Global
From €4490EUR$4,995USD£3,897GBP
- Report
- January 2025
- 144 Pages
Global
From €2663EUR$2,963USD£2,312GBP
€3551EUR$3,950USD£3,082GBP
- Report
- January 2025
- 144 Pages
Global
From €2663EUR$2,963USD£2,312GBP
€3551EUR$3,950USD£3,082GBP
- Report
- March 2024
- 146 Pages
Global
From €2663EUR$2,963USD£2,312GBP
€3551EUR$3,950USD£3,082GBP
- Report
- January 2024
- 146 Pages
Global
From €2865EUR$3,188USD£2,487GBP
€3820EUR$4,250USD£3,316GBP
- Report
- November 2023
- 140 Pages
Global
From €3000EUR$3,338USD£2,604GBP
€4000EUR$4,450USD£3,472GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more